Oracle loses executives health division as several senior leaders depart its health records unit following the Cerner acquisition.

The market continues to stress the company's exposure to OpenAI, not least as Oracle's debt continues to balloon while its cash flow goes in the other direction.

If Oracle maintains this pattern of aggressive short-term rallies, current shareholders could see significant upside from ...

Oracle’s (NYSE: ORCL) 2025 and 2026 stock price sell-off is monumental, creating a generational opportunity for investors. While concerns persist, the critical takeaway is that a robust outlook ...

Oracle stock will remain under pressure until it provides tangible evidence that its spending is paying off.

ORCL's AI backlog surge lifts revenue visibility as cloud jumps 34% y/y and $4B in new AI deals fuel the fiscal 2027 growth outlook.

Oracle shares were up about 3% at $149.45 in early trading. The stock now trades at roughly 19 times projected earnings over ...

Oracle is confirmed as a Buy, despite a post-earnings sell-off and near-term volatility. ORCL's cloud segment surged 34% YoY, now its primary growth engine, while legacy software declined 3%. Massive ...

The company lays out an aggressive new forecast, with a path to nearly quadrupling revenue by fiscal 2030 and a backlog that has already crossed the $500 billion mark Oracle put a key investor concern ...

Oracle is set to transform into a top-tier cloud infrastructure player after securing a $300 billion, five-year deal with OpenAI. The "Stargate" project will see ORCL deliver massive AI data center ...

DTE Energy reports better-than-expected quarterly earnings.